BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ: BNTX)

Overview
current price
$104.96
$104.96
change
1.82 | 1.76%
1.82 | 1.76%
Yesterday's Close
103.14
open
104.32
volume
0.25 M
30d. avg volume.
0.63 M
1 day
104.19 - 107.00
52 weeks
81.20 - 129.27
p/e
0.00
beta
1.5222
market cap
24.79 B
dividend yield
0.00%
Industry
-
News and Commentary
Moderna Reports 8-Fold Jump In Antibodies With Updated Spikevax Moderna Inc. (MRNA&nbs...
Pfizer, BioNTech Roll Out COVID-19 Update That Boosts Antibodies 4-Fold In High-Risk Adults Pfizer Inc. (PFE 
FDA Grants Complete Approval To Moderna's COVID-19 Vaccine For Children As Young As 6 Months The U.S. Food and Drug Administration (FDA) has approved Moderna Inc.'s
Novavax Wins Limited FDA Nod For COVID Shot—Cleared Only For Seniors, High-Risk Groups Amid Safety S... The U.S. Food and Drug Administration has granted limited approval to Novavax Inc.'s
Novavax's COVID-19 Vaccine Nears FDA Full Approval, Stock Jumps Novavax, Inc. (NVAX&nb...
Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows Moderna Inc. (MRNA&nbs...
UK, Taiwan Approve Moderna's Updated COVID-19 Shot On Tuesday, the Medicines and Healthcare Products Regulatory Agency (MHRA) approved Moderna, Inc.'s
Americans To Access COVID-19 Test Kits For Free As US Government Restarts Free At-Home Program Starting in late September, U.S. households can order up to four COVID-19 nasal swab tests when the federal program reopens.The exact date for ordering...
FDA Approves Updated COVID Vaccines From Pfizer And Moderna, But Leaves Out Novavax's Shot Thursday, the FDA granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent (single) component that corresponds to...
Pfizer, BioNTech's COVID-19/Flu Combo Vaccine Fails To Meet Key Goal In Late-Stage Study On Friday, Pfizer Inc. (PFE
StockTwits
StockTwits

Join now and unlock premium features